2025 ICD-10-CM code P70.2
(Active) Effective Date: N/A Revision Date: N/A Deletion Date: N/A Endocrine, Nutritional, and Metabolic Diseases - Transitory endocrine and metabolic disorders specific to newborn Certain conditions originating in the perinatal period (P00-P96) Feed
Neonatal diabetes mellitus, a transient form of diabetes affecting newborns, characterized by hyperglycemia.
Not applicable to ICD-10 codes.
Medical necessity is established by the presence of hyperglycemia and confirmation of a diagnosis of neonatal diabetes mellitus through clinical examination and diagnostic testing.Evidence of impaired insulin production and/or abnormal glucose metabolism needs to be documented to support the diagnosis.In cases of transient diabetes, potential for relapse and long-term management should be addressed.
Diagnosis and management of neonatal diabetes mellitus involves monitoring blood glucose levels, administering insulin therapy (potentially transitioning to oral medication if appropriate), evaluating for associated conditions, providing genetic counseling, and coordinating with specialists as needed (e.g., endocrinologists, geneticists, neonatologists).
- Certain conditions originating in the perinatal period (P00-P96)
- P70-P74 (Transitory endocrine and metabolic disorders specific to newborn)
In simple words: Neonatal diabetes is a type of diabetes that starts in babies. It happens because the baby's body doesn't make enough insulin, a hormone needed to use sugar for energy.This can make the baby's blood sugar go too high. Some babies grow out of it, while others have it for their whole lives.Doctors check for this by looking at the baby's blood sugar levels and may do genetic testing.
Neonatal diabetes mellitus (P70.2) is a rare condition in which a newborn infant has high levels of glucose (sugar) in their blood due to insufficient insulin production. This can be a transient condition (resolving in infancy) or permanent.The transient form, often caused by genetic mutations affecting insulin production or the KATP channel, usually resolves by 18 months, though recurrence is possible later in life.Diagnosis involves clinical signs, hyperglycemia confirmation via laboratory tests showing abnormal insulin levels, and genetic testing. Treatment may involve insulin initially, transitioning to oral medication (such as sulfonylureas) in some cases depending on genetic findings.The condition can present with intrauterine growth retardation, hyperglycemia, dehydration, and occasionally ketoacidosis.
Example 1: A newborn presents with hyperglycemia within the first week of life.Laboratory tests confirm abnormal plasma insulin concentrations. Genetic testing reveals a mutation in the KCNJ11 gene. The infant is initially treated with insulin, but subsequently transitions to oral sulfonylurea therapy based on genetic results., An infant displays symptoms of transient neonatal diabetes, including hyperglycemia and failure to thrive.The condition resolves within 12 months.Genetic testing is negative for known diabetes-causing genes. Further monitoring is required, given the potential for later-onset diabetes., A newborn is diagnosed with neonatal diabetes mellitus secondary to intrauterine growth restriction. The neonate requires insulin treatment due to severe hyperglycemia and ketoacidosis.Close monitoring of glucose levels, hydration status, and electrolyte balance is essential during the initial phase of treatment.Genetic testing is performed to determine the underlying cause.
Comprehensive documentation should include the infant's prenatal history, birth details, clinical presentation (including symptoms and physical examination findings), laboratory results (blood glucose levels, insulin levels, genetic testing results), and treatment plan.Progress notes should reflect response to therapy and any associated complications.
** This code should be used only for neonatal diabetes mellitus diagnosed in the first 28 days of life.It's crucial to differentiate between transient and permanent forms of neonatal diabetes, as treatment and prognosis vary significantly.Genetic testing is highly recommended to guide appropriate management and counseling.
- Revenue Code: Revenue codes will vary depending on the specific services rendered (e.g., laboratory tests, physician visits, hospitalization).
- RVU: RVUs will vary based on the complexity of the case, location of service, and specific procedures performed.Consult appropriate fee schedules for specific payment information.
- Global Days: Not applicable for this ICD-10 code, which represents a diagnosis rather than a procedure.
- Payment Status: Active
- Modifier TC rule: Not applicable to ICD-10 codes.
- Fee Schedule: Not applicable to ICD-10 codes, which are diagnosis codes not procedure codes.
- Specialties:Neonatology, Endocrinology, Genetics, Pediatrics
- Place of Service:Inpatient Hospital, Outpatient Hospital, Neonatal Intensive Care Unit (NICU)